Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) – Zacks Research lifted their Q3 2025 earnings per share estimates for shares of Acadia Healthcare in a report issued on Monday, October 14th. Zacks Research analyst Z. Masood now anticipates that the company will post earnings per share of $1.05 for the quarter, up from their previous forecast of $1.01. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.51 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q2 2026 earnings at $1.06 EPS, Q3 2026 earnings at $1.12 EPS and FY2026 earnings at $4.25 EPS.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The company had revenue of $796.00 million for the quarter, compared to the consensus estimate of $784.38 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. Acadia Healthcare’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period last year, the business posted $0.92 EPS.
Read Our Latest Report on Acadia Healthcare
Acadia Healthcare Trading Down 12.3 %
Shares of NASDAQ:ACHC opened at $52.03 on Thursday. Acadia Healthcare has a 12-month low of $51.07 and a 12-month high of $87.77. The business’s fifty day simple moving average is $70.74 and its 200-day simple moving average is $69.55. The company has a market capitalization of $4.83 billion, a PE ratio of -371.64, a P/E/G ratio of 1.57 and a beta of 1.29. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60.
Institutional Trading of Acadia Healthcare
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Blue Trust Inc. lifted its position in Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the period. Mather Group LLC. acquired a new position in shares of Acadia Healthcare in the 1st quarter valued at about $48,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Acadia Healthcare in the 2nd quarter valued at about $59,000. Finally, nVerses Capital LLC acquired a new position in shares of Acadia Healthcare in the 2nd quarter valued at about $95,000.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
- Five stocks we like better than Acadia Healthcare
- EV Stocks and How to Profit from Them
- Survey Reveals: America’s Most Coveted Businesses in 2024
- How Investors Can Find the Best Cheap Dividend Stocks
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- What Is WallStreetBets and What Stocks Are They Targeting?
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.